Callan Family Office LLC Increases Stock Position in CME Group Inc. $CME

Callan Family Office LLC grew its position in CME Group Inc. (NASDAQ:CMEFree Report) by 431.9% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 13,639 shares of the financial services provider’s stock after purchasing an additional 11,075 shares during the period. Callan Family Office LLC’s holdings in CME Group were worth $3,759,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. GFG Capital LLC purchased a new stake in shares of CME Group in the second quarter valued at about $2,029,000. MSH Capital Advisors LLC increased its holdings in CME Group by 0.9% during the second quarter. MSH Capital Advisors LLC now owns 10,645 shares of the financial services provider’s stock worth $2,934,000 after buying an additional 97 shares during the last quarter. Trifecta Capital Advisors LLC increased its holdings in CME Group by 59.2% during the second quarter. Trifecta Capital Advisors LLC now owns 113 shares of the financial services provider’s stock worth $31,000 after buying an additional 42 shares during the last quarter. Vontobel Holding Ltd. increased its holdings in CME Group by 3.0% during the second quarter. Vontobel Holding Ltd. now owns 2,920,046 shares of the financial services provider’s stock worth $804,823,000 after buying an additional 84,005 shares during the last quarter. Finally, Maryland State Retirement & Pension System increased its holdings in CME Group by 4.0% during the second quarter. Maryland State Retirement & Pension System now owns 17,480 shares of the financial services provider’s stock worth $4,818,000 after buying an additional 671 shares during the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Insider Activity

In other news, insider Timothy Francis Mccourt sold 379 shares of the firm’s stock in a transaction that occurred on Tuesday, September 16th. The shares were sold at an average price of $259.83, for a total value of $98,475.57. Following the completion of the transaction, the insider directly owned 9,508 shares in the company, valued at approximately $2,470,463.64. This trade represents a 3.83% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, General Counsel Jonathan L. Marcus sold 392 shares of the firm’s stock in a transaction that occurred on Thursday, September 18th. The shares were sold at an average price of $262.00, for a total transaction of $102,704.00. Following the completion of the transaction, the general counsel owned 7,851 shares of the company’s stock, valued at $2,056,962. This trade represents a 4.76% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 13,043 shares of company stock valued at $3,527,956 over the last ninety days. 0.30% of the stock is owned by insiders.

Analyst Ratings Changes

A number of analysts recently issued reports on CME shares. JPMorgan Chase & Co. raised their price objective on shares of CME Group from $246.00 to $252.00 and gave the stock an “underweight” rating in a report on Thursday, September 25th. Deutsche Bank Aktiengesellschaft decreased their price objective on shares of CME Group from $276.00 to $266.00 and set a “hold” rating for the company in a report on Thursday. TD Cowen raised their price objective on shares of CME Group from $281.00 to $288.00 and gave the stock a “hold” rating in a report on Wednesday. Wall Street Zen downgraded shares of CME Group from a “hold” rating to a “sell” rating in a report on Sunday, July 13th. Finally, Weiss Ratings restated a “buy (b)” rating on shares of CME Group in a report on Wednesday. Seven research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $281.00.

Check Out Our Latest Report on CME Group

CME Group Price Performance

Shares of NASDAQ:CME opened at $271.45 on Friday. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. The firm has a market capitalization of $97.83 billion, a PE ratio of 26.28, a P/E/G ratio of 5.67 and a beta of 0.41. CME Group Inc. has a twelve month low of $213.94 and a twelve month high of $290.79. The company has a 50-day moving average price of $268.89 and a two-hundred day moving average price of $271.17.

CME Group (NASDAQ:CMEGet Free Report) last released its quarterly earnings data on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, beating analysts’ consensus estimates of $2.91 by $0.05. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The company had revenue of $1.69 billion during the quarter, compared to analyst estimates of $1.68 billion. During the same period last year, the business earned $2.56 earnings per share. CME Group’s revenue was up 10.4% compared to the same quarter last year. Equities analysts forecast that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th were given a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.8%. The ex-dividend date was Tuesday, September 9th. CME Group’s dividend payout ratio (DPR) is 48.40%.

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Further Reading

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.